Matt C. Wilks, PA-C

Matt C. Wilks, PA-C

Biographic:

Born: September 21, 1974

Business:

Dermatology Associates of Knoxville, PC
939 Emerald Avenue, Suite 705
Knoxville, Tennessee 37917
Feb.2003-Present

11416 Grigsby Chapel Road, Suite 100
Knoxville, Tennessee 37934

7557 Dannaher Way, Suite G-20
Powell, TN 37849

Education:

Emory University, Atlanta, Georgia
Masters of Medical Science; PA-C
Graduated with Honors
2000-2001

Maryville College, Maryville, Tennessee
Bachelor of Arts
May, 1997

Professional Experience:

Valdosta Orthopedic Associates
Valdosta, Georgia
Physicians Assistant
January, 2002-January, 2003

Blount Memorial Hospital
Maryville, Tennessee
Head Phlebotomist
June, 1997-August, 1999

Honors:

Dean's List (Fall, 1993, 1996, Spring 1994, 1996, 1997)
National Dean's List (1996, 1997)
All-American Scholar (Fall, 1994)

Professional Associations:

American Academy of Physician Assistants
Georgia Association of Physician Assistants
Allied Health Committee South Georgia Medical Center

Affiliations:

St. Mary's Hospital, Knoxville, Tennessee

Research Experience:

A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site
Clinical Study to Evaluate the Bioequivalence of a Topical Gel Formulation in Patients with Moderate to Severe Rosacea.

A Randomized, Double-blind, Double-dummy, Multicenter, Phase III Study to Assess the Safety and Efficacy of a Topical Ointment versus an Oral Antibiotic in the Treatment of Secondarily-infected Dermatoses.

A Multicenter, Randomized, Double-Blind, Vehicle Controlled Study of the Safety and Efficacy of a Topical Foam in the Treatment of Moderate to Severe Atopic Dermatitis.

A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Two Shampoos in Patients with Tinea (Pityriasis) Versicolor.

A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of an Ointment for the Treatment of Atopic Dermatitis.

A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of a Study Foam versus an FDA approved Cream in the Treatment of Seborrheic Dermatitis.

A Randomized, Double-blind, Parallel-group, Vehicle-Controlled, Multicenter Study to Determine the Safety and Therapeutic Equivalence of a Generic Formulation of a Cream Compared to FDA Approved Cream in the Treatment of Actinic Keratosis

A 5 year Assessment and Tracking of a Long-term Safety Study with a FDA Approved IM Injection in Subjects with Moderate to Severe Chronic Plaque Psoriasis.

A Prospective, Pediatric Longitudinal Evaluation to assess the Long Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis.

A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-site
Study to Evaluate the Equivalence of Two Antifungal Creams in Patients with Interdigital
Tinea Pedis

A Randomized, Double-Blind, Placebo Controlled, Parallel design, Multi-Site
Clinical Study to Evaluate the Bioequivalence of a Generic Ointment to the Already
Marketed Ointment in Patients with Moderate to Severe Plaque Psoriasis.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WATE. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.